Spotlight - Physician's Weekly
SUBSCRIBE TO NEWSLETTERS


Advertisement

ASRS 2023: Retinal Vascular Disease Latest

Aflibercept 8 mg Provides Vision Gains With Fewer Injections in DME

Aug 22, 2023

Among patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (AMD), reducing the treatment burden of frequent injections of VEGF inhibitors is a critical unmet nee....

Racial & Ethnic Diversity Lacking in Diabetic Retinopathy Trials

Aug 21, 2023

Racial & Ethnic Diversity Lacking in Diabetic Retinopathy Trials
Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD

Aug 08, 2023

Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD
Using OCTA Blood Flow Analysis to Detect Early Diabetic Retinopathy

Aug 07, 2023

Using OCTA Blood Flow Analysis to Detect Early Diabetic Retinopathy
Aflibercept 8 mg Vs 2 mg for Wet AMD: Safe & Better Outcomes

Jul 25, 2023

Aflibercept 8 mg Vs 2 mg for Wet AMD: Safe & Better Outcomes
Varied Syringe Accuracy Affects Intravitreal Injection Safety

Jul 25, 2023

Varied Syringe Accuracy Affects Intravitreal Injection Safety
Elevating Diabetic Retinopathy Diagnosis: The Potential of OCTA Bloodflow Analysis

Jul 25, 2023

Elevating Diabetic Retinopathy Diagnosis: The Potential of OCTA Bloodflow Analysis
View all

More Meeting Coverage

ASCO 2023: eNSCLCLatest

Highlights from ASCO 2023 - eNSCLC

Aug 04, 2023

Highlights from ASCO 2023 - eNSCLC
Curative-Intent Treatment Improves Survival in Early NSCLC Regardless of Race

Jun 21, 2023

Curative-Intent Treatment Improves Survival in Early NSCLC Regardless of Race
Greater Benefit of Adjuvant Chemo Noted in High-Risk Patients With eNSCLC

Jun 21, 2023

Greater Benefit of Adjuvant Chemo Noted in High-Risk Patients With eNSCLC
KRAS Mutation Does Not Influence Atezolizumab Response in NSCLC

Jun 12, 2023

KRAS Mutation Does Not Influence Atezolizumab Response in NSCLC
View all

ASCO 2023: HCC

Test Your Knowledge from ASCO on HCC!

Aug 21, 2023

Test Your Knowledge from ASCO on HCC!
Highlights from ASCO 2023 - HCC

Aug 04, 2023

Highlights from ASCO 2023 - HCC
Liver Transplant Outcomes Worse for Black Patients With HCC

Jun 21, 2023

Liver Transplant Outcomes Worse for Black Patients With HCC
Demographics Impact Time to Treatment Initiation for Patients With HCC

Jun 21, 2023

Demographics Impact Time to Treatment Initiation for Patients With HCC
View all

CMSC 2023: MSLatest

Test Your Knowledge from CMSC on MS!

Aug 18, 2023

Test Your Knowledge from CMSC on MS!
Highlights from CMSC 2023

Aug 03, 2023

Highlights from CMSC 2023
In MS, Healthcare Inequities Based on Race & Ethnicity “Still Prevail”

Jun 22, 2023

In MS, Healthcare Inequities Based on Race & Ethnicity “Still Prevail”
Project Helps Improve Communication Between Clinicians & Patients With MS

Jun 20, 2023

Project Helps Improve Communication Between Clinicians & Patients With MS
View all

AAN 2023: MSLatest

Highlights From AAN 2023 - MS

Jun 28, 2023

Highlights From AAN 2023 - MS
MS Therapies Not Associated With Pregnancy Complications

May 22, 2023

MS Therapies Not Associated With Pregnancy Complications
Q&A: Can Remyelination of Axons Restore Vision in MS?

May 19, 2023

Q&A: Can Remyelination of Axons Restore Vision in MS?
Stem Cell Therapy Improves Walking in More Advanced Progressive MS

May 08, 2023

Stem Cell Therapy Improves Walking in More Advanced Progressive MS
View all

AACR 2023: eNSCLCLatest

Test Your Knowledge from AACR 2023 on eNSCLC!

Jun 29, 2023

....

Highlights From AACR 2023

Jun 16, 2023

Highlights From AACR 2023
Orphan Non-Coding RNAs Have Potential for Early Identification of NSCLC

May 19, 2023

Orphan Non-Coding RNAs Have Potential for Early Identification of NSCLC
SphK2 Shows Promise for Overcoming NSCLC Tumor Progression

May 15, 2023

SphK2 Shows Promise for Overcoming NSCLC Tumor Progression
Adherence to Imaging Guidelines ‘Very Poor’ After Early NSCLC Treatment

May 01, 2023

Adherence to Imaging Guidelines ‘Very Poor’ After Early NSCLC Treatment
Novel Scoring System Helps Validate High-Risk Features of eNSCLC

Apr 18, 2023

Novel Scoring System Helps Validate High-Risk Features of eNSCLC
AACR Virtual Meeting Platform

Apr 10, 2023

AACR Virtual Meeting Platform
View all

CROI 2023Latest

Test Your CROI Knowledge on HIV

May 03, 2023

....

Higher Stroke Risk in Women With HIV Driven By Age & Comorbidities

Apr 30, 2023

Higher Stroke Risk in Women With HIV Driven By Age & Comorbidities
Read Our CROI eBook!

Apr 25, 2023

Read Our CROI eBook!
Diabetes, Weight Gain & Integrase Inhibitor Use Examined in PWH

Mar 23, 2023

Diabetes, Weight Gain & Integrase Inhibitor Use Examined in PWH
Risk Factors for 5-Year Mortality in PWH Following Cancer Diagnosis

Mar 10, 2023

Risk Factors for 5-Year Mortality in PWH Following Cancer Diagnosis
In HIV, Mental Health Impacts Viral Suppression, But Not Retention in Care

Mar 08, 2023

In HIV, Mental Health Impacts Viral Suppression, But Not Retention in Care
HIV Persistence Markers Reduction in ART-Treated Adults by Doubling Dolutegravir Dosage

Feb 22, 2023

HIV Persistence Markers Reduction in ART-Treated Adults by Doubling Dolutegravir Dosage
View all

ASCO GI 2023Latest

Test Your ASCO GI on HCC Knowledge!

Apr 05, 2023

....

ASCO GI eBook

Mar 23, 2023

ASCO GI eBook
Hepatic Resection Linked With Better OS After RT+TACE for HCC With MVI

Feb 15, 2023

Hepatic Resection Linked With Better OS After RT+TACE for HCC With MVI
Novel Regimen May Avoid TME Surgery in Rectal Cancer

Feb 02, 2023

Novel Regimen May Avoid TME Surgery in Rectal Cancer
IMbrave 151 Missed Primary Endpoint in Advanced BTC

Jan 27, 2023

IMbrave 151 Missed Primary Endpoint in Advanced BTC
New Standard of Care for Colorectal Cancer

Jan 27, 2023

New Standard of Care for Colorectal Cancer
SWOG 1815, First-Ever Phase 3 Trial in BTC, Fails

Jan 27, 2023

SWOG 1815, First-Ever Phase 3 Trial in BTC, Fails
View all

ASH 2022: LymphomaLatest

ASH Lymphoma eBook

Feb 21, 2023

Focus on ASH Lymphoma 2023v2.indd....

CAR-Hematotox Score Predicts Toxicity, Infection & Clinical Outcomes in MCL

Dec 19, 2022

CAR-Hematotox Score Predicts Toxicity, Infection & Clinical Outcomes in MCL
Metabolic Tumor Volume Predicts Response to Loncastuximab Tesirine in DLBCL

Dec 16, 2022

Metabolic Tumor Volume Predicts Response to Loncastuximab Tesirine in DLBCL
Odronextamab Scores in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Dec 15, 2022

Odronextamab Scores in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
High-Dose Chemotherapy Plus ASCT Superior to Standard Immune-Chemotherapy in Primary CNS Lymphoma

Dec 15, 2022

High-Dose Chemotherapy Plus ASCT Superior to Standard Immune-Chemotherapy in Primary CNS Lymphoma
Ibrutinib Added to ASCT Improves Clinical Outcomes in Mantle Cell Lymphoma

Dec 15, 2022

Ibrutinib Added to ASCT Improves Clinical Outcomes in Mantle Cell Lymphoma
ASH Schedule At A Glance

Dec 06, 2022

View all

ASH 2022: LeukemiaLatest

Test Your Knowledge from ASH on Leukemia!

Jan 30, 2023

....

ASH 2022: Leukemia eBook

Jan 23, 2023

ASH 2022: Leukemia eBook
Factors Associated With Improved COVID-19 Outcomes for CLL

Dec 21, 2022

Factors Associated With Improved COVID-19 Outcomes for CLL
MRD by qPCR Prognostic of Outcomes in Venetoclax-Treated, NPM1-Mutated AML

Dec 19, 2022

MRD by qPCR Prognostic of Outcomes in Venetoclax-Treated, NPM1-Mutated AML
Excellent Results for Triplet Regimen in FLT3-Mutated AML

Dec 19, 2022

Excellent Results for Triplet Regimen in FLT3-Mutated AML
Ibrutinib Delays Need for Next Treatment in Real-World First-Line CLL

Dec 19, 2022

Ibrutinib Delays Need for Next Treatment in Real-World First-Line CLL
Blinatumomab Candidate for Standard-of-Care in Newly Diagnosed B-ALL

Dec 15, 2022

Blinatumomab Candidate for Standard-of-Care in Newly Diagnosed B-ALL
View all

ACR 2022Latest

Test Your ACR Knowledge!

Dec 21, 2022

The ACR 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. ....

ACR eBook

Dec 21, 2022

ACR eBook
Quality of Gout Care Suboptimal Among Aged Care Residents

Dec 09, 2022

Quality of Gout Care Suboptimal Among Aged Care Residents
Aggressive Serum Urate Lowering Meets Goals in Gout

Dec 05, 2022

Aggressive Serum Urate Lowering Meets Goals in Gout
Gout Has Causal Role in the Onset of Hypertension

Dec 02, 2022

Neutrophil-to-Lymphocyte Ratio in Gout Suggests Sustained Post-Flare Inflammation

Nov 29, 2022

Neutrophil-to-Lymphocyte Ratio in Gout Suggests Sustained Post-Flare Inflammation
Patients With Comorbid Gout Hospitalized With COVID-19 Have Greater LOS

Nov 18, 2022

Patients With Comorbid Gout Hospitalized With COVID-19 Have Greater LOS
View all

AHA 2022Latest

Test Your AHA Knowledge!

Dec 19, 2022

....

AHA 2022 eBook

Dec 14, 2022

AHA 2022 eBook
Baseline Cholesterol Biomarkers Impact CV Risk in Elderly Patients

Nov 15, 2022

Baseline Cholesterol Biomarkers Impact CV Risk in Elderly Patients
Returning Secondary Findings Related to Hypercholesterolemia Has Clinical Benefits

Nov 15, 2022

Returning Secondary Findings Related to Hypercholesterolemia Has Clinical Benefits
PCSK9 Monoclonal Antibody Provides ‘Significant and Durable’ Decrease in LDL-C

Nov 15, 2022

PCSK9 Monoclonal Antibody Provides ‘Significant and Durable’ Decrease in LDL-C
VICTORION-INCEPTION: Inclisiran Immediately After ACS for Secondary Prevention

Nov 15, 2022

VICTORION-INCEPTION: Inclisiran Immediately After ACS for Secondary Prevention
ORION-3: Long-Term Inclisiran Safe & Feasible

Nov 15, 2022

ORION-3: Long-Term Inclisiran Safe & Feasible
View all

Kidney Week 2022Latest

Test Your ASN Knowledge!

Dec 16, 2022

The ASN 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. ....

ASN 2022 eBook

Dec 13, 2022

ASN 2022 eBook
PROTECT Trial: Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients

Dec 06, 2022

PROTECT Trial: Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients
MIRROR RCT Trial: Addressing Gout Following Kidney Transplant

Nov 21, 2022

MIRROR RCT Trial: Addressing Gout Following Kidney Transplant
Gout More Prevalent in Black Adults Than in Whites, Especially Black Women

Nov 14, 2022

Gout More Prevalent in Black Adults Than in Whites, Especially Black Women
Link Found Between Gout Flare and Subsequent Cardiovascular Events

Nov 14, 2022

Link Found Between Gout Flare and Subsequent Cardiovascular Events
Day #1 Meeting Schedule

Oct 28, 2022

View all

ECTRIMS 2022: NMOSDLatest

Test Your ECTRIMS on NMOSD Knowledge!

Dec 14, 2022

The ECTRIMS NMOSD 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. ....

ECTRIMS NMOSD eBook

Dec 07, 2022

ECTRIMS NMOSD eBook
Ravulizumab Significantly Reduces Relapses in AQP4+ NMOSD

Nov 08, 2022

Ravulizumab Significantly Reduces Relapses in AQP4+ NMOSD
Inebilizumab Effective in NMOSD Despite Fc Receptor Polymorphisms

Nov 08, 2022

Inebilizumab Effective in NMOSD Despite Fc Receptor Polymorphisms
Patients With NMOSD Cognitively Impaired Regardless of Serostatus

Nov 04, 2022

Patients With NMOSD Cognitively Impaired Regardless of Serostatus
New Data on the Safety of Anti-CD20 mAbs Around Pregnancy

Nov 04, 2022

New Data on the Safety of Anti-CD20 mAbs Around Pregnancy
NMOSD: True AQP4 Seroconversion Is Rare

Nov 04, 2022

NMOSD: True AQP4 Seroconversion Is Rare
View all

ECTRIMS 2022: Multiple SclerosisLatest

Test Your ECTRIMS on MS Knowledge!

Dec 14, 2022

....

ECTRIMS MS eBook

Dec 07, 2022

ECTRIMS MS eBook
Cognitive Rehab & Mindfulness Reduce Cognitive Complaints in MS

Nov 08, 2022

Cognitive Rehab & Mindfulness Reduce Cognitive Complaints in MS
MS Activity & Pregnancy Outcomes After Long-Term Natalizumab

Nov 08, 2022

MS Activity & Pregnancy Outcomes After Long-Term Natalizumab
Efficacy of DMTs Fades in Secondary Progressive MS

Nov 08, 2022

Efficacy of DMTs Fades in Secondary Progressive MS
MS Associated With a Broader Epstein-Barr Virus-Specific, T-Cell Receptor Repertoire

Nov 08, 2022

MS Associated With a Broader Epstein-Barr Virus-Specific, T-Cell Receptor Repertoire
AHSCT Not Superior to Natalizumab in Progressive MS

Nov 08, 2022

AHSCT Not Superior to Natalizumab in Progressive MS
View all

ACG 2022Latest

ACG eBook

Dec 21, 2022

ACG IBS 2022.indd....

Test Your Knowledge on ACG

Dec 09, 2022

Test Your Knowledge on ACG
Patients With IBS With Diarrhea Experience Significant Burden on HRQOL

Nov 29, 2022

Patients With IBS With Diarrhea Experience Significant Burden on HRQOL
Patients With IBS With Diarrhea Experience Significant Burden on HRQOL

Nov 28, 2022

IgG-Based Diets Can Provide Relief for Some Patients With IBS

Nov 15, 2022

IgG-Based Diets Can Provide Relief for Some Patients With IBS
Half of IBS Videos Shared on TikTok Posted by Influencers

Nov 08, 2022

Half of IBS Videos Shared on TikTok Posted by Influencers
Gut-Directed Hypnotherapy Via Mobile App Improves IBS Symptoms

Nov 08, 2022

Gut-Directed Hypnotherapy Via Mobile App Improves IBS Symptoms
View all

SOHO 2022Latest

Test Your SOHO Knowledge!

Dec 19, 2022

....

SOHO 2022 eBook

Dec 06, 2022

SOHO 2022 eBook
For Refractory/Relapsed AML, Total Therapy Proves Superior to Standard Care

Nov 15, 2022

For Refractory/Relapsed AML, Total Therapy Proves Superior to Standard Care
Survival Benefit With IVO-AZA Combo for Acute Myeloid Leukemia

Oct 19, 2022

Survival Benefit With IVO-AZA Combo for Acute Myeloid Leukemia
In Hematologic Cancer, Orca-T Reduced GVHD

Oct 19, 2022

In Hematologic Cancer, Orca-T Reduced GVHD
For Patients With AML, IVO/VEN/AZA Combo Bolsters Survival

Oct 11, 2022

For Patients With AML, IVO/VEN/AZA Combo Bolsters Survival
SOHO 2022 COVID-19 Plan

Sep 26, 2022

SOHO 2022 COVID-19 Plan
View all
Advertisement